Skip to main content
NIHPA Author Manuscripts logoLink to NIHPA Author Manuscripts
. Author manuscript; available in PMC: 2015 Feb 20.
Published in final edited form as: J Genet Couns. 2011 Jul 20;20(6):639–649. doi: 10.1007/s10897-011-9389-2

Using a Family History Intervention to Improve Cancer Risk Perception in a Black Community

Vinaya S Murthy 1, Mary A Garza 2, Donna A Almario 3, Kristen J Vogel 4, Robin E Grubs 5, Elizabeth A Gettig 5, John W Wilson 3, Stephen B Thomas 2
PMCID: PMC4335264  NIHMSID: NIHMS639811  PMID: 21773879

INTRODUCTION

Although Americans have recently experienced an increase in life expectancy and overall health, not everyone is benefiting equally from medical advances and public health Campaigns (Sullivan Commission, 2004; Groman and Ginsburgh, 2004). African Americans (AA) have the highest death rate and shortest survival of any racial and ethnic group in the United States for most cancers, including breast and colorectal cancer, both of which are most effectively treated in early stages (ACS, 2011). In 2011, approximately 169,000 new cancer cases will occur among AA, of which the most commonly diagnosed cancers among men are prostate (PRCA) (40%), lung (15%), and colorectal (CRC) (9%) and among women, breast (BRCA) (34%), lung (13%), and colorectal (11%) (ACS, 2011). The lack of progress at reducing disparities in cancer mortality has been attributed to low screening rates leading to later diagnoses, socioeconomic factors, inaccurate cancer risk perceptions, clinician screening recommendations, and mistrust of the healthcare system (Bloom, 2006; Facion, 2007; Sadler, 2007; Griffith, 2008; Ward, 2008).

Risk perception, a complex cognitive process influenced by a variety of factors and unique to each individual, can be a driving force in an individual’s decision to undertake preventive health action (Yoon, 2003; Sivell, 2008; Ward, 2008). Risk perception is a central theoretical construct in recognized models of health behavior change, including but not limited to the Health Belief Model, the Precaution Adoption Model, and the Transactional Model of Stress and Coping (Vernon, 1999; NCI, 2005; Sivell, 2008). An individual’s risk perception, which derives from threat appraisal, can be most relevant for changing health behaviors (Vernon, 1999).

Research has shown that interventions have been beneficial in improving risk perceptions for BRCA, CRC, and PRCA (Carlos, 2005; DiLorenzo, 2006; Pavic, 2007). Moreover, perceived risk is often a motivator for positive health-related behaviors, particularly with respect to cancer screenings. For example, women are becoming more knowledgeable about breast cancer risk and as a result are more closely adhering to screening guidelines (Powe, 2004; Blumenthal, 2005; Basch, 2006; Pavic, 2007). Blumenthal and colleagues evaluated culturally appropriate media messages related to screening and found that among AA participants these interventions were associated with an increase in BRCA, CRC, and PRCA screenings (Blumenthal, 2005).

Elevated risk perception has been associated with family history (FH) (Watson, 1999; Hopwood, 2003; Warner, 2003). Furthermore, individuals with a FH of a given disorder are more likely to engage in disease prevention behaviors for that disorder (McCaul, 1996; Petersen, 1999; Bloom, 2006). Although research has been inconclusive regarding the relationship between perceived risk, family history, and screening intentions for PRCA and CRC among AA, some studies have shown an association (Bloom, 2006; Katz, 2007; Griffith, 2008; Spain, 2008). Codori et al. found that a strong family history of CRC was associated with better adherence to sigmoidoscopy screening (Codori, 1999; Yoon, 2002; Yoon, 2003). Among AA women with a positive family history of BRCA, participants were more inclined to adhere to mammography and clinical breast examination recommendations (Halbert, 2006; Laing, 2008).

In 2004, the U.S. Surgeon General announced the Family Health Initiative, a national campaign to promote the use of FH for disease prevention and health promotion (DSHS, 2004). The use of genetic information, particularly FH, has the potential to identify at-risk individuals and provide opportunities for education, prevention, and early diagnosis. In addition, FH can lay the foundation for accurate risk perception and appropriately identify at-risk individuals for targeted, risk-reducing interventions (Guttmacher, 2004).

One approach to address health disparities among AA is to investigate the process of documenting family histories as an intervention to influence risk perception and motivate at-risk individuals to engage in protective health behaviors. Family history alone has been shown to be a significant risk factor for various cancers. Yoon and colleagues summarized several case-control studies that have shown an increased relative risk associated with one or more affected first-degree relatives among individuals in the general population with a family history of BRCA, CRC, and PRCA (Yoon, 2002). Using FH information to identify AA at increased cancer risk may lead to improved screening in moderate- and high-risk individuals, thereby decreasing the disease burden in this population and contributing to the reduction of health disparities.

The University of Pittsburgh’s Graduate School of Public Health Center for Minority Health (CMH) developed the Family Health History Initiative in 2003 to explore the utility of family health histories (FHH) as an intervention to improve knowledge of cancer risk. The development of this initiative has been previously described by Vogel et al. (Vogel, 2007) and is a component of the Healthy Black Family Project (HBFP), a community-based intervention designed to prevent diabetes and cardiovascular disease (Thomas, 2008). Two aims of this initiative were to 1) determine the accuracy of AA participants’ risk perceptions for common diseases, including various cancers and 2) understand how participants’ perceptions were influenced by FHH interviews. The outcomes of these aims are reported in this paper.

METHODS

Participants

AA participants were recruited from the greater urban Pittsburgh area between May 2004 and June 2008. The study population was drawn from the Health Empowerment Zone (HEZ) in the East End of Pittsburgh, a geographic region defined by urban residential neighborhoods consisting of at least 60% black residents, 20% below the federal poverty line, and considered to be medically underserved (Thomas, 2008). Locations were selected within two predominantly black (72.5% and 97% African American residents) neighborhoods, East Liberty and Homewood-Brushton in the HEZ (Thomas, 2008). Recruitment took place in various community settings, including churches, retirement centers, community health fairs/events, barbershops and beauty salons, and community centers in these neighborhoods. In addition, participants were recruited through word-of-mouth networks (Thomas, 2008; Ford, 2009). Participants were eligible if they were 18 years or older, spoke and read English, and were able to provide informed consent.

The study proceeded in three stages for each participant: 1) a pre-session survey documenting demographics and disease risk perceptions, 2) an interview session recording and assessing each participant’s family history, and 3) a post-session survey documenting disease risk perceptions. The pre- and post- session surveys were each designed to take approximately 20 minutes to complete. The interview session was designed to take 30 minutes with time allotted for risk assessment. We compared pre- and post-FHH risk perceptions to the Scheuner risk classification system—high, moderate, and average risk (Scheuner, 1997). All study procedures were reviewed and approved by the Human Subjects Institutional Review Board of the University of Pittsburgh.

Instrumentation

The pre-session survey instrument collected demographic characteristics, including age, gender, self-reported racial/ethnic background, income, education, and general health and insurance status. Participants were asked to evaluate their perceived genetics knowledge, presented as “how would you rate your knowledge on genetics?” with response options coded as excellent, very good, good, fair and poor. Thus, genetic knowledge was self-reported. Additionally, participants were asked about their perceptions on general risk factors for chronic disease including smoking, poor diet, FH, and physical activity. Participants were asked “how often do you believe each of these factors increases or contributes to an individual’s chance or risk of developing a disease such as diabetes, heart disease and cancer?” with response options coded using a Likert-style scale: 1 (Never), 2 (Sometimes), 3 (Always), or 4 (Don’t know/not sure).

The pre- and post- session surveys explored participant’s risk perceptions for nine chronic diseases. The diseases surveyed include heart disease, diabetes, hypertension, Alzheimer’s disease, cancers of the breast, colon, lung, ovary and prostate. Participants were asked the following question: “Based on your FHH, what do you think your chances are of developing any of the following health conditions sometime in your life?” Participants reported their perceived risks using a Likert-style scale: 1 (Low = < 10%), 2 (Moderate = 10–50%), to 3 (High = > 50%). Participants were also given the option to answer “don’t know.” The present analysis is focused on risk perceptions relating to BRCA, CRC, and PRCA due to the prevalence of these cancers among AA and known genetic contributions.

Our survey questions on risk perception were informed by the face validity of existing instruments published in the literature (Hughes, 1996; Hopwood, 2001). We were unable to identify any validated survey to explore risk perceptions among African Americans.

Procedures

Vogel et al. have previously described the FHH sessions, in which participants completed family history interviews with Master’s-level genetic counseling (GC) students (Vogel, 2007). Over the 5 year (2004–2008) recruitment period, a total of 11 genetic counseling students from the Department of Human Genetics in the University of Pittsburgh’s Graduate School of Public Health served as Graduate Research Assistants in the CMH and were dedicated to conducting family health histories. Each student served a two year rotation. In any given year, one to three students were performing FHH in the community. Of these 11 students, eight self-identified as Caucasian, one of mixed race (Caucasian and Asian), one Asian, and one African American. Ten of the 11 students were female and all were between the ages of 22 and 31 (Smith, 2010). Participants constituted a sample of convenience, recruited at community health fairs, barbershop outreach, church events, etc. Counseling students scheduled interviews based upon their workload and the availability of the participant.

The GC students completed appropriate training prior to taking FHH and performing risk assessments. Family health history information was recorded by creating a pedigree using standard pedigree nomenclature (Bennett, 1995; Vogel, 2007). Upon completion of gathering a participant’s FHH, the GC students assessed the participant’s FHH and discussed the participant’s objective risks for various conditions. The students’ risk assessments were based on the guidelines developed by Scheuner and colleagues for stratifying risk based on FH information (Bennett, 1995; Scheuner, 1997).

Data Analysis

We examined the percent distribution of objective risk using the Scheuner guidelines and participants’ risk perceptions pre- and post-FHH. Predictors of change in risk perception post-FHH were examined. Several variables were created to construct the final outcome variable risk perception change post-FHH. Initially, a variable was created that determined the accuracy of pre-FHH risk perception as compared to objective risk. For example, if a person reported average pre-FHH risk, and her/his objective risk was average, then s/he would be categorized as accurate pre-FHH. If the person perceived her/his risk as average but the objective risk was high, then s/he would be categorized as inaccurate pre-FHH. A similar variable was constructed for accuracy and inaccuracy post-FHH. These variables were used to construct the final outcome variable. If an individual was accurate or inaccurate at both pre- and post-FHH, s/he would be categorized as unchanged. If the individual was inaccurate at pre-, but became accurate at post-FHH, or vice versa, s/he would be categorized as changed.

Logistic regression was used to examine whether each variable predicted change in risk perception post-FHH. Initial models were unadjusted and examined to determine whether each variable alone significantly predicted risk perception change. Multiple logistic regression was performed to examine whether variables remained significant after including other predictors (> 50 years of age, income, education, self-reported general health, knowledge of genetics, accuracy of risk perception at pre-FHH, perceptions of poor diet, lack of exercise, smoking, and FH, health insurance status, having a healthcare provider, and whether participant had difficulty seeing a doctor in the last 12 months). The mean age for this sample was 52 years; thus, to facilitate statistical analysis, the age category cut-off was 50 years. Interactions were also assessed between accuracy at pre-FHH and the following variables: self-reported health status as fair/poor and risk perceptions related to poor diet, lack of exercise, smoking, and FH.

Exclusion criteria

Participants’ responses were excluded from the risk perception analysis for the specified cancer if they reported to have been diagnosed with the condition. A total of 19, 7, and 9 individuals were excluded for BRCA, CRC, and PRCA, respectively, given self-reported diagnoses. Since the majority of participants were female, we excluded males from risk perceptions related to BRCA. Also, we only included male responses to risk perception questions on PRCA. Therefore, the number of participants will vary for each disease. In addition, participants who responded “don’t know” or had missing responses were excluded from accuracy of risk perception analysis and logistic regression analysis. Participants with missing data on covariates were also excluded from logistic regression analysis.

RESULTS

Demographics, Self-Reported Health, and Perceived Knowledge of Genetics

Individuals who agreed to complete their FHH (n=797) were offered participation in the study, and those who were interested completed pre- and post-session surveys (n=683 or 85%) after informed consent was obtained. Of those who completed the surveys, 665 (83%) participants self-identified as AA and were included in the analyses.

Table I provides a summary of participants’ demographic characteristics. Of 665 AA participants, 84% of participants were women and the mean age was 52 years. Seventy-seven percent had at least some college education and 41% had incomes of at least $35,000. The majority of individuals reported their general health as good or higher (71%), and almost half perceived their knowledge of genetics as either good, very good, or excellent (49.5%).

Table 1.

Demographic data of family health history participants (n = 665)

All participants
n %
Male 104 15.6
Female 561 84.4
Age
≤50 282 42.4
>50 383 57.6
Mean Age (SD) 52.38 (13.37)
Income
≤$20,000 185 27.8
$20,001 to $35,000 159 23.8
$35,001 to $50,000 119 17.9
≥$50,001 to $75,000 154 23.2
Missing 49 7.4
Education
≤ High School Education 149 22.4
Some College (to 3 years) 303 45.6
College Graduate or Post Graduate Education 208 31.3
Missing 5 0.8
Self-Reported General Health
Excellent/Very Good 128 19.3
Good 345 51.9
Fair/Poor 185 27.8
Missing 7 1.1
Knowledge of Genetics
Excellent/Very Good 72 10.8
Good 258 38.8
Fair/Poor 320 48.1
Missing 15 2.3
Have Health Insurance
No 65 9.8
Yes 593 89.2
Don’t Know / Not Answered 7 1.1
Have a Healthcare Provider
No 35 5.3
Yes, only 1 395 59.4
Yes, >1 226 34
Don’t Know / Not Answered 9 1.4
Needed to see MD in past 12 months but could not because of cost
No 566 85.1
Yes 92 13.8
Don’t Know / Not Answered 7 1.1

Of the 665 participants, 81.4% (n = 541) provided risk perception for BRCA (includes all unaffected women), 79.3% (n = 528) for CRC (of whom 84.1% or 444 were women), and 14.1% (n = 94) for PRCA (includes all unaffected men). Characteristics of participants who provided risk perceptions for BRCA and CRC were similar. Men providing their risk perceptions for PRCA tended to have higher incomes (earning more than $50,000), to report very good/excellent health status, and to perceive themselves as having very good/excellent knowledge of genetics.

Of the 665 participants, 81.4% (n=541) provided risk perception for BRCA (includes all unaffected women), 79.3% (n=528) for CRC (of whom 84.1% or 444 were women), and 14.1% (n=94) for PRCA (includes all unaffected men). Characteristics for participants who provided risk perceptions for BRCA and CRC were similar. Men providing their risk perceptions for PRCA tended to have higher incomes (earning more than $50,000), to report very good/excellent health status, and to perceive very good/excellent knowledge of genetics.

Perceived Risk Factors

We assessed individuals’ perceptions of various risk factors (having a poor diet, lack of exercise, smoking, and FH) associated with the development of a chronic disease (table not presented). The majority of individuals (62% to 75%) perceived that poor diet, lack of exercise, and smoking were always risk factors for chronic disease, in general. In contrast, a smaller percentage (42%) found that having a FH of a disease was always a risk factor.

Objective Cancer Risk

Participants’ objective risks, using the Scheuner guidelines for family history for BRCA, CRC, and PRCA, are presented in Table II. For each of these cancers, most participants had an average objective risk, n=462 or 85%, n=591 or 90%, and n=80 or 85%, respectively. Fewer participants were found to have moderate risk (n=42 or 7.8% for BRCA, n=48 or 7.3% for CRC, and n=13 or 13.8% for PRCA) and high risk (n=37 or 6.8% for BRCA, n=16 or 2.4% for CRC, and n=1 or 1.1% for PRCA).

Table 2.

Objective and perceived cancer risk based on Family Health History (FHH)

Objective disease risk based on FHH Perceived disease risk, before FHH Perceived disease risk, after FHH Difference from Pre to Post
n % n % n % %
Breast Cancer (n = 541)
Average 462 85.4 215 39.7 314 58 18.3
Moderate 42 7.8 210 38.8 153 28.3 −10.5
High 37 6.8 50 9.2 43 8 −1.2
Don’t Know 47 8.7 19 3.5 −5.2
Missing 19 3.5 12 2.2 −1.3
Colon Cancer (n = 655)
Average 591 90.2 293 44.7 385 58.8 14.1
Moderate 48 7.3 195 29.8 178 27.2 −2.6
High 16 2.4 58 8.9 38 5.8 −3.1
Don’t Know 79 12.1 33 5 −7.1
Missing 30 4.6 21 3.2 −1.4
Prostate Cancer (n = 94)
Average 80 85.1 21 22.3 33 35.1 12.8
Moderate 13 13.8 40 42.6 40 42.6 0
High 1 1.1 18 19.2 11 11.7 −7.5
Don’t Know 7 7.5 5 5.3 −2.2
Missing 8 8.5 5 5.3 −3.2

Perceived Cancer Risk

Table II summarizes participants’ perceived risks prior to and following the FHH intervention. Prior to the FHH session, most participants perceived themselves to have average or moderate risk to develop BRCA (average=39.7%; moderate=38.8%), CRC (average=44.7%; moderate=29.8%) and PRCA (average=22.3%; moderate=42.6%). We found that 9.2% and 8.9% of participants perceived their BRCA and CRC risk, respectively, as high and one-fifth (19.2%) of males perceived their PRCA risk as high.

Post-FHH average risk perceptions for BRCA (58.0%), CRC (58.8%), and PRCA (35.1%) increased compared to before their FHH (Table II). Fewer participants perceived themselves to be at high risk for BRCA, CRC, and PRCA (8.0%, 5.8%, and 11.7%, respectively).

Accuracy of Cancer Risk Perception

Table III shows perception accuracy pre- and post-FHH. While there were a number of individuals who remained inaccurate and a smaller number who were accurate pre-FHH and inaccurate post-FHH for all three cancers, the majority of participants (292/463 or 63.1% for BRCA; 349/528 or 66.1% for CRC) had accurate risk perceptions post-FHH. For PRCA, fewer participants (32/77 or 41.6%) were accurate post-FHH. Of those who were inaccurate pre-FHH, we found that 104 (or 43.3%) for BRCA, 103 (or 43.8%) for CRC, and 19 (or 34.5%) for PRCA adopted accurate risk perceptions as a result of the FHH session.

Table 3.

Accuracy of risk perceptions pre- and post-family health history using objective disease risk

Disease risk n %
Breast Cancer (n = 463)
Inaccurate Pre and Inaccurate Post 136 29.40%
Accurate Pre and Accurate Post 188 40.60%
Inaccurate Pre and Accurate Post 104 22.50%
Accurate Pre and Inaccurate Post 35 7.60%
% Accurate Post/Total (104 + 188/463) 63.10%
% Accurate Post/Total Inaccurate Pre (104/136 + 104) 43.30%
Colon Cancer (n = 528)
Inaccurate Pre and Inaccurate Post 132 25.00%
Accurate Pre and Accurate Post 246 46.60%
Inaccurate Pre and Accurate Post 103 19.50%
Accurate Pre and Inaccurate Post 47 8.90%
% Accurate Post/Total (47 + 246/528) 66.10%
% Accurate Post/Total Inaccurate Pre (103/132 + 103) 43.80%
Prostate Cancer (n = 77)
Inaccurate Pre and Inaccurate Post 36 46.80%
Accurate Pre and Accurate Post 13 16.90%
Inaccurate Pre and Accurate Post 19 24.70%
Accurate Pre and Inaccurate Post 9 11.70%
% Accurate Post/Total (13 + 19/77) 41.50%
% Accurate Post/Total Inaccurate Pre (19/36 + 19) 34.50%

Individuals were excluded if they had missing responses, responded “don’t know,” or had the specified cancer(s). In addition, female participants were only included for the breast cancer analysis and male participants were only included for prostate cancer analysis.

Factors Predictive of Change in Cancer Risk Perceptions Post-Family Health History

Table IV shows the results from logistic regression models. In the initial univariate logistic regression, most variables were not significant predictors of change in risk perception, except for inaccuracy at pre-FHH and self-reported fair/poor health status. Individuals whose risk perceptions changed for BRCA and CRC post-FHH were roughly four times (95% CI 2.63-6.83 for BRCA, 2.85-6.75 for CRC) more likely to change if they were inaccurate at pre-FHH than if they were accurate. Other covariates (demographic characteristics, perceived knowledge of genetics, perception of general risk factors, insurance status, and cost) were adjusted for and results showed that inaccuracy at pre-FHH remained a significant predictor of change in BRCA (OR: 4.63, 95% CI 2.85-7.51) and CRC risk perceptions (OR: 4.28, 95% CI 2.74-6.70) post-FHH. Self-reported fair/poor health status for CRC, which initially was a significant predictor of change in risk perception (OR=1.88, 95% CI 1.22-2.88), was no longer a significant predictor of change after controlling for other covariates (OR: 1.61, 95% CI 0.99-2.62). There were no significant predictors of change in risk perception for PRCA. Interactions between inaccuracy and the following variables: self-reported fair/poor health status and risk perceptions relating to poor diet or having a FH of a disease were not significant.

Table 4.

Factors associated with change in risk perception: results from unadjusted and adjusted multiple regression

Variable Unadjusted Adjusteda
Odds Ratio 95% CI Odds Ratio 95% CI
Breast Cancer (n = 410)
Inaccurate Risk Perception Pre-Family History 4.27 2.63–6.83 4.63 2.85–7.51
Fair/Poor Self-Reported Health 1.03 0.64–1.65 0.9 0.53–1.54
Having a Family History Always Increases Risk for Disease 0.92 0.61–1.41 0.82 0.50–1.34
Poor Diet Always Increases Risk for Disease 0.77 0.49–1.22 0.71 0.38–1.33
Colon Cancer (n = 470)
Inaccurate Risk Perception Pre-Family History 4.39 2.85–6.75 4.28 2.74–6.70
Fair/Poor Self-Reported Health 1.88 1.22–2.88 1.61 0.99–2.62
Having a Family History Always Increases Risk for Disease 1.05 0.71–1.58 0.9 0.57–1.44
Poor Diet Always Increases Risk for Disease 1.25 0.80–1.96 1.45 0.78–2.70
Prostate Cancer (n = 72)
Inaccurate Risk Perception Pre-Family History 0.73 0.26–2.05 0.9 0.24–3.34
Fair/Poor Self-Reported Health 2.06 0.72–5.89 1.39 0.36–5.33
Having a Family History Always Increases Risk for Disease 0.35 0.10–1.19 0.29 0.07–1.26
Poor Diet Always Increases Risk for Disease 0.38 0.14–1.02 0.22 0.04–1.39

BOLD indicates significance

a

Adjusted for the following covariates: inaccuracy at pre-FH, >50 years of age, income, education, self-report of fair/poor health, perception that smoking, poor diet, lack of exercise, or having a family history of disease is always a risk factor, having one or more healthcare providers, having health insurance, and needed to see MD in past 12 months but could not because of cost

DISCUSSION

In this community-based study, we evaluated the influence of FHH interviews on AA risk perceptions of BRCA, CRC, and PRCA. We targeted AA because they have higher mortality rates for these cancers than Caucasians in Allegheny County and represent an underserved population (PA DOH, 2002; Thomas, 2008). We examined whether FHH interviews could promote more accurate risk perceptions for cancer. More importantly, we intended to raise awareness about FH as a risk factor for cancer, encourage participants to discuss FH with their family and physicians, and inform participants about appropriate cancer screening guidelines.

We found that study participants appropriately identified smoking, poor diet, physical inactivity, and FH as disease-contributing factors. However, they were less confident about the role of FH. Participants’ uncertainties may stem from a lack of understanding and/or healthcare provider communication about FH and disease. Public health campaigns have focused attention on and developed interventions educating AA on the negative effects of smoking, the importance of a healthy diet, and the necessity of engaging in routine physical activity (Royce, 1993; Paschal, 2004; Lewis, 2005; Fu, 2008). It is noteworthy that each of these factors is amenable to behavior change through health promotion and disease prevention efforts. Only with the recent advancements stemming from the Human Genome Project and personalized medicine have national public health initiatives begun to aggressively educate healthcare providers and the public on the relevance of FH not only as a risk factor for disease but also as a potential motivator for adoption of healthy lifestyles (Yoon, 2002; Frezzo, 2003; Guttmacher, 2004; DSHS, 2004).

Prior to the FHH intervention, many of our participants tended to overestimate their cancer risks. Our findings are consistent with past reports that show individuals in the general population often overestimate or misinterpret cancer risks (Watson, 1999; Hopwood, 2003; Bloom, 2006; Odedina, 2008; Spain, 2008). A meta-analysis by Meiser and Halliday evaluated studies that explored risk perception accuracy among individuals undergoing BRCA genetic counseling. They concluded that individuals at risk for BRCA had significantly improved risk perceptions after genetic counseling (Meiser, 2002). Butow and colleagues also had similar observations in their systematic review (Butow, 2003). However, Butow et al. also found that there was a proportion (22–50%) of individuals who still overestimated their risk post-counseling. The majority of studies evaluated by Meiser and Butow focused on BRCA genetic counseling of predominantly Caucasian participants in high risk clinics. Interestingly, we had similar observations in our community-based study with AA participants.

A recent systematic review by Smerecnik et al. focused on the impact of genetic counseling on risk perception accuracy and extended the previous reviews by Meiser and Butow to other genetic conditions including various cancers as well as non-cancerous conditions (Smerecnik, 2009). Similar to Butow et al, they concluded that genetic counseling may have a positive impact on risk perception accuracy (Smerecnik, 2009). Smerecnik reported that some studies observed no effect on risk perception accuracy at all, or only found changes among low-risk individuals. Among those studies that assessed the proportion of individuals who accurately estimated their risk, Smerecnik et al. determined that there was an average increase of approximately 25% (range: 2-55%) of counselees who correctly estimated their risk after counseling; from an average of 42% pre-counseling to an average of 58% post-counseling. However, on average 25% (range 7-55%) continued to overestimate their risks and 19.5% (range: 7-55%) underestimated their risks post-counseling (Smerecnik, 2009). Our findings are consistent with these studies in that the majority of participants in our study had accurate risk perceptions post-FHH for BRCA and CRC; however, we also found that some participants either overestimated or underestimated their risks following the intervention.

Possible explanations for continuing to have inaccurate cancer risk perceptions post-genetic counseling may include inadequacy of the communication process, difficulties by the counseled individual in comprehending or remembering the information given, personal experience with disease, age of participants, media misrepresentation of general cancer risks, and differences in risk presentation format by healthcare providers (Hopwood, 2000; Meiser, 2002; Hopwood, 2003; Smerecnik, 2009). According to Matthews, “many AA have unspoken beliefs or concerns about illness that influence their attitudes and perceptions about cancer” (Matthews, 2000, p. 14). Therefore, cultural beliefs such as cancer as a taboo topic, negative perceptions regarding cancer survivability, general anxiety with cancer screening, and the belief that focusing on cancer may lead to developing cancer may have contributed to inaccurate cancer risk perceptions post-FHH among our study participants. Further research is needed to better delineate these associations and to identify solutions for cancer education targeting African Americans.

In our study, AA men were more likely to have inaccurate risk perceptions for PRCA post-FHH (45/77 or 58.4%). Studies have shown that AA men often have inaccurate risk perceptions for PRCA, which suggests a need for interventions designed to educate AA men about the role of FH in determining PRCA risk (Bloom, 2006; Odedina, 2008; Spain, 2008). Documenting a family history, making AA men more aware of their risks, and providing information regarding available screenings and risk-reducing behaviors may improve risk perceptions and screening practices (Scheuner, 1997; Frezzo, 2003; Yoon, 2003).

Study Limitations

A number of limitations apply to this study. First, our participants were self-referred and therefore may not be representative of the AA population in Pittsburgh. The majority of our participants were educated AA women with health insurance coverage. Based on a three-year US Census Bureau estimate (2007-2009) of Pittsburgh’s demographic profile, the majority of adults aged 25+ had at least a high-school education (90.6%) and were insured (90.4%) (Pittsburgh Indicators Project, 2011). Although our study participants had similar health insurance coverage (89%), they had less education (78%) compared to the US Census estimate for Pittsburgh residents.

The nature of the HBFP with its focus on lifestyle behavior change and low impact physical activity was attractive to AA women who recruited their family and friends. This is not an unanticipated outcome given that women tend to seek health information for themselves and their families more often than men and are likely to utilize it in health care decisions (Copeland, 2000). The HBFP, specifically the FHH Initiative, provided a non-threatening means for participants to learn about the importance of FH in relation to patterns of chronic disease.

Another limitation of the study is that knowledge of genetics was assessed by self-report and not with the use of a validated instrument. Therefore, participants may have over or under estimated their knowledge of genetics. Additionally, although the interview team informed all potential participants that knowledge of their FHH was not a prerequisite to participate in the study, some individuals may have refused due to lack of knowledge about the types of disease and causes of death among their family members.

Vogel et al. described other challenges to enrollment including inability to quantify the number of potential participants and difficulty in contacting those who indicated interest in participation (Vogel, 2007). Another limitation is that our data rely on participant recall rather than medical documentation, which may lead to inaccurate classification of objective risk.

Research Recommendations

In the future, we plan to explore risk perception recall and whether participants’ perceptions change over time. We plan to expand our study to explore participants’ communications of FH information with family members and healthcare providers as well as the impact of the intervention on participants’ willingness to engage in healthy behaviors and cancer screenings. We may also consider community venues that exclusively serve men (e.g., barbershops, fraternities, and sporting events) as a means to increase male participation in the FHH Initiative. Finally, the study design can be strengthened by use of a validated instrument on knowledge of genetics as a means to increase the reliability and validity of changes in knowledge before and after the FHH interview over time.

Implications for Genetic Counseling Practice

We explored the use of FHH as an intervention and its influence on participants’ perceptions of risk. We learned that for many a FHH intervention in a non-clinical setting can lead to accurate cancer risk perceptions. According to Etchegary et al. (2007),

“In the context of genetic counseling, at risk people may hold beliefs about their own risk derived largely from the pattern of disease expression in their families. These beliefs can be used to negate or exaggerate their actual risk, and as such, may preclude the systematic processing of risk information discussed during counseling or the acceptance of risk-reducing protective behaviors. Indeed, family history of illness is a powerful influence on personal genetic-risk perception…” (Etchegary, 2007, pg. 421).

An interesting and remarkable outcome of this initiative is how well the FHH intervention resonated with AA participants. It is possible that techniques utilized by genetic counselors assimilate traditions of black oral history. The FHH intervention lends itself to cultural values that are based in the AA community and oral history traditions (Banks-Wallace, 2002). It is noteworthy that our approach provided genetic counseling students, the majority of whom were not African American, the opportunity to learn about these cultural values and to have a deeper understanding of the lives of study participants in a manner not often experienced by genetic counselors trained and practicing in traditional clinical settings alone.

Genetic counselors are increasingly interacting with individuals of diverse racial and cultural backgrounds. Moreover, gaps in effective communication continue to be pervasive in health care and contribute to disparities in health. As stated by Thomas et al. (2004),

“Efforts to eliminate health disparities must be informed by the influence of culture on the attitudes, beliefs, and practices of not only minority populations but also public health policymakers and the health professionals responsible for the delivery of medical services and public health interventions designed to close the health gap” (p. 2050)).

Therefore, genetic counselors can engage in this effort by not only understanding their own racial and cultural identities, but pursuing education and training opportunities that promote awareness of the cultural attitudes, beliefs and practices of the clients they serve (Ota Wang, 2001).

The successful recruitment of African American study participants in our study was made possible by working in partnership with credible, opinion leaders with shared values of the target community and operating out of trusted venues such as black barbershops, beauty salons, community centers and black churches. This combination of working with trusted leaders and recruiting in community settings facilitated our ability to communicate key messages on health, family history, and preventive screening. Most importantly these messages were reinforced by active participation in the Healthy Black Family Project.

Conclusions

As the dialogues and public health education campaigns continue, the public will become more aware of FH as a risk factor which may positively influence health behaviors. A detailed FHH can be useful in identifying individuals in the general population who may be at increased risk to develop cancer and targeted for personalized prevention strategies.

Today, practicing genetic counselors have great challenges to overcome in serving patient populations, and have adapted by diversifying their skills to provide nontraditional counseling, including phone-and web-based, telemedicine, and contract services. Similarly, genetic counseling training programs could benefit from developing strategies to provide experiences for GC students to be engaged in the community by partnering with community-based organizations serving underserved communities. Additionally, practicing genetic counselors can benefit from continuing education and training opportunities that enrich their understanding of the diverse cultural beliefs, attitudes, and values of our patient populations. This approach is in concert with the vision and mission of genetic counselors to integrate genetics and genomics to improve health outcomes and to provide quality genetic services and education (NSGC, 2011). The HBFP Family Health History Initiative demonstrated the feasibility of launching such a program outside of the clinical environment.

Many AA participants commented that the experience of documenting the FHH and seeing the information on paper “opened their eyes.” As stated by Dr. David Satcher, “the greatest opportunities for reducing health disparities are in empowering individuals to make informed healthcare decisions and in providing the skills, education, and care necessary to improve health” (Satcher, 2000). Family health histories may serve as the bridge between patients and providers by incorporating cultural traditions to improve health communication and increase uptake of preventive measures, in order to reduce disease burden.

Acknowledgment

This research was supported by the National Institutes of Health, National Institute on Minority Health and Health Disparities (PG60MD000207, S.B. Thomas, PI) and National Cancer Institute, Mentored Career Development Award (7K01CA140358-02, M.A. Garza, PI).

We graciously thank our community partners and the participants in the Healthy Black Family Project. We would also like to acknowledge the following genetic counseling students: Vinaya Murthy, Kristen Vogel, Beth Dudley, Katie Hoffman, Leah Slattery, Vera Cherepakho, Melissa Watson, Kim Amburgey, Chris Lauricella, Sarah Woody, and Andrea Smith, who conducted the interviews.

REFERENCES

  1. American Cancer Society (ACS) Cancer facts and figures for African Americans 2011–2012. Atlanta, GA: 2011. [Google Scholar]
  2. Austin JC. Re-conceptualizing Risk in Genetic Counseling: Implications for Clinical Practice. J Genet Couns. 2010;19(3):228–234. doi: 10.1007/s10897-010-9279-z. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Banks-Wallace J. Talk that talk: Storytelling and analysis rooted in African American oral tradition. Qual Health Res. 2002;12(3):410–426. doi: 10.1177/104973202129119892. [DOI] [PubMed] [Google Scholar]
  4. Basch CE, Wolf RL, et al. Telephone outreach to increase colorectal cancer screening in an urban minority population. Am J Public Health. 2006;96(12):2246–2253. doi: 10.2105/AJPH.2005.067223. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Bennett P, et al. The impact of breast cancer genetic risk assessment on intentions to perform cancer surveillance behaviors. J Genet Couns. 2007;16(5):617–623. doi: 10.1007/s10897-007-9100-9. [DOI] [PubMed] [Google Scholar]
  6. Bennett RL, Steinhaus KA, et al. Recommendations for standardized human pedigree nomenclature. Pedigree Standardization Task Force of the National Society of Genetic Counselors. Am J Hum Genet. 1995;56(3):745–752. [PMC free article] [PubMed] [Google Scholar]
  7. Bloom JR, Stewart SL, et al. Family history, perceived risk, and prostate cancer screening among African American men. Cancer Epidemiol Biomarkers Prev. 2006;15(11):2167–2173. doi: 10.1158/1055-9965.EPI-05-0738. [DOI] [PubMed] [Google Scholar]
  8. Blumenthal DS, Fort JG, et al. Impact of a two-city community cancer prevention intervention on African Americans. J Natl Med Assoc. 2005;97(11):1479–1488. [PMC free article] [PubMed] [Google Scholar]
  9. Butow PN, Lobb EA, et al. Psychological outcomes and risk perception after genetic testing and counselling in breast cancer: a systematic review. Med J Aust. 2003;178(2):77–81. doi: 10.5694/j.1326-5377.2003.tb05069.x. [DOI] [PubMed] [Google Scholar]
  10. Carlos RC, Underwood W, et al. Behavioral associations between prostate and colon cancer screening. J Am Coll Surg. 2005;200(2):216–223. doi: 10.1016/j.jamcollsurg.2004.10.015. [DOI] [PubMed] [Google Scholar]
  11. Codori AM, Petersen GM, et al. Attitudes toward colon cancer gene testing: factors predicting test uptake. Cancer Epidemiol Biomarkers Prev. 1999;8(4 Pt 2):345–351. [PubMed] [Google Scholar]
  12. Copeland VC, Scholle SH. Patient Satisfaction and African American Women: A Missing Link in Health Services Research. African American Perspectives. 2000;6(2):48–56. [Google Scholar]
  13. Department of Health and Human Services (DSHS) [Retrieved June 12, 2009];Family History Initiative. 2004 2009, from http://www.hhs.gov/familyhistory.
  14. DiLorenzo TA, Schnur J, et al. A model of disease-specific worry in heritable disease: the influence of family history, perceived risk and worry about other illnesses. J Behav Med. 2006;29(1):37–49. doi: 10.1007/s10865-005-9039-y. [DOI] [PubMed] [Google Scholar]
  15. Etchegary H, Perrier C. Information processing in the context of genetic risk: Implications for genetic-risk communication. J Genet Couns. 2007;16(4):419–432. doi: 10.1007/s10897-006-9082-z. [DOI] [PubMed] [Google Scholar]
  16. Facione NC, Facione PA. Perceived prejudice in healthcare and women's health protective behavior. Nurs Res. 2007;56(3):175–184. doi: 10.1097/01.NNR.0000270026.90359.4c. [DOI] [PubMed] [Google Scholar]
  17. Ford A, Quinn S, Reddick K, Browne M, Robins A, Thomas S. Beyond the cathedral: building trust to engage the African American community in health promotion and disease prevention. Health Promotion Practice. 2009;10(4):485–489. doi: 10.1177/1524839909342848. [DOI] [PubMed] [Google Scholar]
  18. Frezzo TM, Rubinstein WS, et al. The genetic family history as a risk assessment tool in internal medicine. Genet Med. 2003;5(2):84–91. doi: 10.1097/01.GIM.0000055197.23822.5E. [DOI] [PubMed] [Google Scholar]
  19. Fu SS, Kodl MM, et al. Racial/Ethnic disparities in the use of nicotine replacement therapy and quit ratios in lifetime smokers ages 25 to 44 years. Cancer Epidemiol Biomarkers Prev. 2008;17(7):1640–1647. doi: 10.1158/1055-9965.EPI-07-2726. [DOI] [PMC free article] [PubMed] [Google Scholar]
  20. Griffith KA, McGuire DB, et al. Influence of family history and preventive health behaviors on colorectal cancer screening in African Americans. Cancer. 2008;113(2):276–285. doi: 10.1002/cncr.23550. [DOI] [PubMed] [Google Scholar]
  21. Groman R, Ginsburg J. Racial and ethnic disparities in health care: a position paper of the American College of Physicians. Ann Intern Med. 2004;141(3):226–232. doi: 10.7326/0003-4819-141-3-200408030-00015. [DOI] [PubMed] [Google Scholar]
  22. Guttmacher AE, Collins FS, et al. The family history--more important than ever. N Engl J Med. 2004;351(22):2333–2336. doi: 10.1056/NEJMsb042979. [DOI] [PubMed] [Google Scholar]
  23. Halbert CH, Kessler L, et al. Breast cancer screening behaviors among African American women with a strong family history of breast cancer. Prev Med. 2006;43(5):385–388. doi: 10.1016/j.ypmed.2006.06.003. [DOI] [PubMed] [Google Scholar]
  24. Hopwood P. Breast cancer risk perception: what do we know and understand? Breast Cancer Res. 2000;2(6):387–391. doi: 10.1186/bcr83. [DOI] [PMC free article] [PubMed] [Google Scholar]
  25. Hopwood P, Howell A, et al. Do women understand the odds? Risk perceptions and recall of risk information in women with a family history of breast cancer. Community Genet. 2003;6(4):214–223. doi: 10.1159/000079383. [DOI] [PubMed] [Google Scholar]
  26. Hopwood P, Shenton A, et al. Risk perception and cancer worry: an exploratory study of the impact of genetic risk counselling in women with a family history of breast cancer. J Med Genet. 2001;38(2):139. doi: 10.1136/jmg.38.2.139. [DOI] [PMC free article] [PubMed] [Google Scholar]
  27. Hughes C, Lerman C, et al. Ethnic differences in risk perception among women at increased risk for breast cancer. Breast Cancer Res Treat. 1996;40(1):25–35. doi: 10.1007/BF01806000. [DOI] [PubMed] [Google Scholar]
  28. Katz ML, Tatum C, et al. Improving colorectal cancer screening by using community volunteers: results of the Carolinas cancer education and screening (CARES) project. Cancer. 2007;110(7):1602–1610. doi: 10.1002/cncr.22930. [DOI] [PMC free article] [PubMed] [Google Scholar]
  29. Laing SS, Makambi K. Predicting regular breast cancer screening in African- American women with a family history of breast cancer. J Natl Med Assoc. 2008;100(11):1309–1317. doi: 10.1016/s0027-9684(15)31510-8. [DOI] [PubMed] [Google Scholar]
  30. Lewis LB, Sloane DC, et al. African Americans' access to healthy food options in South Los Angeles restaurants. Am J Public Health. 2005;95(4):668–673. doi: 10.2105/AJPH.2004.050260. [DOI] [PMC free article] [PubMed] [Google Scholar]
  31. Matthews AK, Cummings S, et al. Genetic testing of African Americans for susceptibility to inherited cancers: Use of focus groups to determine factors contributing to participaton. J Psychosoc Oncol. 2000;18(2):1–19. [Google Scholar]
  32. McCaul KD, Schroeder DM, et al. Breast cancer worry and screening: some prospective data. Health Psychol. 1996;15(6):430–433. doi: 10.1037//0278-6133.15.6.430. [DOI] [PubMed] [Google Scholar]
  33. Meiser B, Halliday JL. What is the impact of genetic counselling in women at increased risk of developing hereditary breast cancer? A meta-analytic review. Soc Sci Med. 2002;54(10):1463–1470. doi: 10.1016/s0277-9536(01)00133-2. [DOI] [PubMed] [Google Scholar]
  34. National Cancer Institute (NCI) Theory at a Glance: Application to Health Promotion and Health Behavior (Second Edition) 2005. [Google Scholar]
  35. National Society of Genetic Counselors. [Retrieved May 16, 2011];Vision and Mission Statement. 2011 from http://www.nsgc.org/
  36. Odedina FT, Campbell ES, et al. Personal factors affecting African-American men's prostate cancer screening behavior. J Natl Med Assoc. 2008;100(6):724–733. doi: 10.1016/s0027-9684(15)31350-x. [DOI] [PubMed] [Google Scholar]
  37. PA Department of Health (PA DOH) State Health Improvement Plan: Special report on the health status of minorities in Pennsylvania. Harrisburgh, PA: 2002. [Google Scholar]
  38. Paschal AM, Lewis RK, et al. Baseline assessment of the health status and health behaviors of African Americans participating in the activities-for-life program: a community-based health intervention program. J Community Health. 2004;29(4):305–318. doi: 10.1023/b:johe.0000025328.35205.cd. [DOI] [PubMed] [Google Scholar]
  39. Pavic D, Schell MJ, et al. Comparison of three methods to increase knowledge about breast cancer and breast cancer screening in screening mammography patients. Acad Radiol. 2007;14(5):553–560. doi: 10.1016/j.acra.2007.01.011. [DOI] [PubMed] [Google Scholar]
  40. Petersen GM, Larkin E, et al. Attitudes toward colon cancer gene testing: survey of relatives of colon cancer patients. Cancer Epidemiol Biomarkers Prev. 1999;8(4 Pt 2):337–344. [PubMed] [Google Scholar]
  41. Pittsburgh Indicators Project. [Retrieved May 19, 2011];Key indicators for understanding our region. 2011 from http://www.pittsburghtoday.org/view_Race_view2.html on.
  42. Powe BD, Ntekop E, et al. An intervention study to increase colorectal cancer knowledge and screening among community elders. Public Health Nurs. 2004;21(5):435–442. doi: 10.1111/j.0737-1209.2004.21507.x. [DOI] [PubMed] [Google Scholar]
  43. Royce JM, Hymowitz N, et al. Smoking cessation factors among African Americans and whites. COMMIT Research Group. Am J Public Health. 1993;83(2):220–226. doi: 10.2105/ajph.83.2.220. [DOI] [PMC free article] [PubMed] [Google Scholar]
  44. Sadler GR, Ko CM, et al. Breast cancer knowledge, attitudes, and screening behaviors among African American women: the Black cosmetologists promoting health program. BMC Public Health. 2007;7:57. doi: 10.1186/1471-2458-7-57. [DOI] [PMC free article] [PubMed] [Google Scholar]
  45. Satcher D. Surgeon General. Partnerships for Health in the New Millennium conference. 2000 [Google Scholar]
  46. Scheuner MT, Wang SJ, et al. Family history: a comprehensive genetic risk assessment method for the chronic conditions of adulthood. Am J Med Genet. 1997;71(3):315–324. doi: 10.1002/(sici)1096-8628(19970822)71:3<315::aid-ajmg12>3.0.co;2-n. [DOI] [PubMed] [Google Scholar]
  47. Sivell S, Elwyn G, et al. How risk is perceived, constructed and interpreted by clients in clinical genetics, and the effects on decision making: systematic review. J Genet Couns. 2008;17(1):30–63. doi: 10.1007/s10897-007-9132-1. [DOI] [PubMed] [Google Scholar]
  48. Smerecnik CM, Mesters I, et al. A systematic review of the impact of genetic counseling on risk perception accuracy. J Genet Couns. 2009;18(3):217–228. doi: 10.1007/s10897-008-9210-z. [DOI] [PMC free article] [PubMed] [Google Scholar]
  49. Smith AL. Human Genetics. Pittsburgh: University of Pittsburgh; 2010. An assessment of the factors associated with willingness of African Americans to participate in a minority research recruitment database. [Google Scholar]
  50. Spain P, Carpenter WR, et al. Perceived family history risk and symptomatic diagnosis of prostate cancer: the North Carolina Prostate Cancer Outcomes study. Cancer. 2008;113(8):2180–2187. doi: 10.1002/cncr.23801. [DOI] [PMC free article] [PubMed] [Google Scholar]
  51. Sullivan Commission. [Retrieved March 1 2005];Missing Persons: Minorities in the Health Professions A report of the Sullivan Commission on Diversity in the Healthcare Workforce. 2004 from http://www.sullivancommission.org/.
  52. Thomas SB, Fine MJ, Ibrahim SJ. Health disparities: the importance of culture and health communication. Am J Public Health. 2004;94(12):2050. doi: 10.2105/ajph.94.12.2050. [DOI] [PMC free article] [PubMed] [Google Scholar]
  53. Thomas SB, Quinn SC. Poverty and elimination of urban health disparities: challenge and opportunity. Ann N Y Acad Sci. 2008;1136:111–125. doi: 10.1196/annals.1425.018. [DOI] [PubMed] [Google Scholar]
  54. Vernon SW. Risk perception and risk communication for cancer screening behaviors: a review. J Natl Cancer Inst Monogr. 1999;(25):101–119. doi: 10.1093/oxfordjournals.jncimonographs.a024184. [DOI] [PubMed] [Google Scholar]
  55. Vogel KJ, Murthy VS, et al. The use of family health histories to address health disparities in an African American community. Health Promot Pract. 2007;8(4):350–357. doi: 10.1177/1524839906293395. [DOI] [PubMed] [Google Scholar]
  56. Ota Wang V. Multicultural genetic counseling: Then now in the 21st century. Am J Med Genet. 2001;106(3):208–215. doi: 10.1002/ajmg.10009. [DOI] [PubMed] [Google Scholar]
  57. Ward SH, Lin K, et al. Increasing colorectal cancer screening among African Americans, linking risk perception to interventions targeting patients, communities and clinicians. J Natl Med Assoc. 2008;100(6):748–758. doi: 10.1016/s0027-9684(15)31356-0. [DOI] [PMC free article] [PubMed] [Google Scholar]
  58. Warner E, Carroll JC, et al. Educating women about breast cancer. An intervention for women with a family history of breast cancer. Can Fam Physician. 2003;49:56–63. [PMC free article] [PubMed] [Google Scholar]
  59. Watson M, Lloyd S, et al. The impact of genetic counselling on risk perception and mental health in women with a family history of breast cancer. Br J Cancer. 1999;79(5 – 6):868–874. doi: 10.1038/sj.bjc.6690139. [DOI] [PMC free article] [PubMed] [Google Scholar]
  60. Yoon PW, Scheuner MT, et al. Research priorities for evaluating family history in the prevention of common chronic diseases. Am J Prev Med. 2003;24(2):128–135. doi: 10.1016/s0749-3797(02)00585-8. [DOI] [PubMed] [Google Scholar]
  61. Yoon PW, Scheuner MT, et al. Can family history be used as a tool for public health and preventive medicine? Genet Med. 2002;4(4):304–310. doi: 10.1097/00125817-200207000-00009. [DOI] [PubMed] [Google Scholar]

RESOURCES